Fir Tree Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-60,932
Closed -$22.7M 728
2021
Q3
$22.7M Sell
60,932
-2,268
-4% -$862K 0.77% 24
2021
Q2
$24.1M Sell
63,200
-64,870
-51% -$24.8M 0.91% 21
2021
Q1
$46M Sell
128,070
-6,682
-5% -$2.15M 1.84% 10
2020
Q4
$43.3M Buy
134,752
+66,387
+97% +$20.4M 2.1% 14
2020
Q3
$18.4M Sell
68,365
-4,557
-6% -$1.23M 0.93% 28
2020
Q2
$19.2M Sell
72,922
-83,364
-53% -$22.2M 1.49% 18
2020
Q1
$35.5M Buy
156,286
+84,964
+119% +$23.2M 3.13% 11
2019
Q4
$21.5M Buy
71,322
+36,389
+104% +$10M 2.13% 15
2019
Q3
$8.39M Buy
+34,933
New +$9.57M 0.82% 27

Other funds holding ELV

Fir Tree Capital Management's ELV Position: Q4 2021 in Review

Fir Tree Capital Management sold out of Elevance Health (ELV) in Q4 2021, closing a stake of 60,932 shares — an estimated $22.7M sold.

Fir Tree Capital Management first reported a position in ELV in Q3 2019 and held it in 9 quarters. The position peaked at $46M in Q1 2021. 1,372 funds tracked by Wall St. Rank hold ELV as of Q4 2021.

  • Fir Tree Capital Management reported no remaining Elevance Health position as of Q4 2021 after selling out during the quarter.
  • Fir Tree Capital Management sold 60,932 Elevance Health shares in Q4 2021, an estimated $22.7M.
  • Fir Tree Capital Management first reported a position in Elevance Health in Q3 2019 and held it in 9 quarters.
  • Fir Tree Capital Management's Elevance Health position peaked at $46M in Q1 2021.
  • 1,372 funds tracked by Wall St. Rank held Elevance Health as of Q4 2021.

Based on Fir Tree Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.